C

CenExel Clinical Research | CBH Health

Research site
(Unclaimed)
Location
9318 Gaither Road, Unit 220 & Unit 265, Gaithersburg, Maryland, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

9 of 42
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

A clinical study that will evalute how well SEP-363856 works and how safe it is in people with schizophrenia that switch to SEP-363856 from their cur...

Active, not recruiting
Schizophrenia
Drug: SEP-363856

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving dep...

Enrolling
Depressive Disorder, Major
Anhedonia
Other: Placebo
Drug: Aticaprant

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Enrolling
Depressive Disorder, Major
Drug: Aticaprant

An Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that sw...

Invitation-only
Schizophrenia
Drug: SEP-363856

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compul...

Enrolling
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling
Treatment Resistant Depression
Drug: Psilocybin

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

NMDA antagonist drugs have shown to reduce symptoms of depression and suicidal ideation. NeuroRx has developed NRX-101 (fixed dose combination of D-c...

Active, not recruiting
Suicidal Ideation and Behavior
Bipolar Depression
Drug: Lurasidone HCl
Drug: NRX-101

Trial conditions

Schizophrenia (22 trials)
Depression (14 trials)
Depressive Disorder (14 trials)
Major Depressive Disorder (10 trials)
Treatment-Resistant Depr... (4 trials)
Psychotic Disorders (3 trials)
Suicidal Ideation (3 trials)
Bipolar Disorder (2 trials)
Cognitive Dysfunction (2 trials)
Compulsive Personality D... (2 trials)

And 8 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems